AlphaFold predicted structure
SMARCD2 · Q92925

Mean pLDDT
76.1/ 100
Confident
531 residues
Confidence breakdown
- Very high(≥ 90)54%
- Confident(70–90)14%
- Low(50–70)4%
- Very low(< 50)28%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
SWI/SNF related BAF chromatin remodeling complex subunit D2
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
COVID-19 research
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalAmelogenesis imperfecta
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalRare syndromic craniosynostosis or isolated multisuture synostosis
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownRecurrent infection due to specific granule deficiency
autosomal recessive severe congenital neutropenia
hereditary disease
Premature ovarian insufficiency
metabolic syndrome
metabolic dysfunction-associated steatotic liver disease
fatty liver disease
neuroblastoma
Hepatic steatosis
Blackfan-Diamond anemia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2
Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner (PubMed:22952240, PubMed:26601204). Critical regulator of myeloid differentiation, controlling granulocytopoiesis and the expression of genes involved in neutrophil granule formation (PubMed:28369036)
SMARCD2 · Q92925

Mean pLDDT
76.1/ 100
Confident
531 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0